Annexon, Inc. ANNX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

58/100

3/6 Pass

SharesGrow Intrinsic Value

Annexon, Inc. (ANNX) has 17 既知のインサイダーおよび機関投資家保有者の記録. 最大保有者は Satter Muneer A 9,306,024 株保有. その他の主要保有者には Bain Capital Life Sciences Investors, LLC および Love Douglas.

過去12ヶ月間にインサイダーは 40 件の取引を実施 ANNX 株式 — 27 件の買い (評価額 $16.29M) および 13 件の売り (評価額 $321.42K). インサイダーの買いが売りを上回っており、会社の見通しに対する自信の表れかもしれません.

ANNX インサイダー保有状況

最大保有者

Satter Muneer A

9,306,024 株

買い（12ヶ月）

$16.29M 評価額

売り（12ヶ月）

$321.42K 評価額

12ヶ月取引活動

買い 68%

売り 33%

インサイダー上位保有者

#	氏名	役職	保有株数	最終申告日	相対規模
1	Satter Muneer A	Director	9,306,024	2025-11-21	100%
2	Bain Capital Life Sciences Investors, Llc	10 Percent Owner	5,401,926	2023-05-30	58%
3	Love Douglas	President and CEO	1,250,000	2026-02-23	13%
4	Overdorf Michael	EVP & Chief Business Officer	182,625	2026-03-04	2%
5	Artis Dean Richard	EVP & Chief Scientific Officer	180,093	2026-03-04	2%
6	Lew Jennifer	EVP & Chief Financial Officer	170,700	2026-03-04	2%
7	Yednock Ted	EVP & Chief Innovation Officer	154,161	2026-03-04	2%
8	Dananberg Jamie	Chief Medical Officer	123,582	2026-03-04	1%
9	Carson William H.	Director	62,405	2026-03-12	1%
10	Wiggans Thomas G	Director	55,000	2025-06-09	1%
11	Cockroft Bettina M.	Director	55,000	2025-06-09	1%
12	Jones William A Jr	Director	55,000	2025-06-09	1%
13	Waddill William D.	Director	55,000	2025-06-09	1%
14	Mattheakis Larry	EVP & Chief Scientific Officer	37,500	2022-07-13	0%
15	Choi Jung	Director	33,000	2025-12-03	0%
16	Keswani Sanjay	EVP & Chief Medical Officer	12,500	2022-02-15	0%
17	Sun Ricky	Director	10,000	2021-06-04	0%

最近の取引 (過去12ヶ月)

日付	氏名	役職	種類	株数	株価	価値
2026-03-10	Carson William H.	Director	情報に基づく買い	8,000	$5.67	$45.36K
2026-03-02	Artis Dean Richard	EVP & Chief Scientific Officer	情報に基づく売り	5,894	$5.43	$32K
2026-03-02	Yednock Ted	EVP & Chief Innovation Officer	情報に基づく売り	5,566	$5.42	$30.17K
2026-03-02	Overdorf Michael	EVP & Chief Business Officer	情報に基づく売り	4,339	$5.42	$23.52K
2026-03-02	Dananberg Jamie	Chief Medical Officer	情報に基づく売り	5,820	$5.43	$31.6K
2026-03-02	Lew Jennifer	EVP & Chief Financial Officer	情報に基づく売り	5,565	$5.42	$30.16K
2026-02-19	Artis Dean Richard	EVP & Chief Scientific Officer	RSU 付与（制限付株式）	62,500	-	-
2026-02-19	Yednock Ted	EVP & Chief Innovation Officer	RSU 付与（制限付株式）	62,500	-	-
2026-02-19	Overdorf Michael	EVP & Chief Business Officer	RSU 付与（制限付株式）	62,500	-	-
2026-02-19	Love Douglas	President and CEO	RSU 付与（制限付株式）	1,250,000	$5.10	$6.38M
2026-02-19	Dananberg Jamie	Chief Medical Officer	RSU 付与（制限付株式）	56,250	-	-
2026-02-19	Lew Jennifer	EVP & Chief Financial Officer	RSU 付与（制限付株式）	62,500	-	-
2026-02-18	Artis Dean Richard	EVP & Chief Scientific Officer	情報に基づく売り	5,290	$5.10	$26.98K
2026-02-18	Yednock Ted	EVP & Chief Innovation Officer	情報に基づく売り	7,857	$5.11	$40.15K
2026-02-18	Overdorf Michael	EVP & Chief Business Officer	情報に基づく売り	6,225	$5.10	$31.75K
2026-02-18	Dananberg Jamie	Chief Medical Officer	情報に基づく売り	5,290	$5.10	$26.98K
2026-02-18	Lew Jennifer	EVP & Chief Financial Officer	情報に基づく売り	7,851	$5.11	$40.12K
2025-12-30	Carson William H.	Director	情報に基づく買い	4,115	$5.02	$20.66K
2025-12-01	Carson William H.	Director	情報に基づく買い	4,115	$4.47	$18.39K
2025-12-01	Choi Jung	Director	情報に基づく買い	33,000	$4.19	$138.27K
2025-11-21	Satter Muneer A	Director	情報に基づく買い	422,613	$4.28	$1.81M
2025-11-20	Satter Muneer A	Director	情報に基づく買い	400,000	$4.48	$1.79M
2025-11-19	Satter Muneer A	Director	情報に基づく買い	500,000	$3.94	$1.97M
2025-11-18	Satter Muneer A	Director	情報に基づく買い	500,000	$3.18	$1.59M
2025-11-17	Satter Muneer A	Director	情報に基づく買い	500,000	$2.99	$1.5M